Rheumatoid Arthritis

You have full text access to this OnlineOpen article

Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis†

  1. S. M. van der Kooij1,‡,*,
  2. J. K. de Vries-Bouwstra2,§,
  3. Y. P. M. Goekoop-Ruiterman1,
  4. J. A. P. M. Ewals3,
  5. K. H. Han4,
  6. J. M. W. Hazes5,¶,
  7. P. J. S. M. Kerstens6,
  8. A. J. Peeters7,
  9. D. van Zeben8,
  10. F. C. Breedveld1,‖,
  11. T. W. J. Huizinga1,
  12. B. A. C. Dijkmans2,††,
  13. C. F. Allaart1,‡‡

Article first published online: 30 DEC 2008

DOI: 10.1002/art.24367

Issue

Arthritis Care & Research

Arthritis Care & Research

Volume 61, Issue 1, pages 4–12, 15 January 2009

Additional Information

How to Cite

van der Kooij, S. M., de Vries-Bouwstra, J. K., Goekoop-Ruiterman, Y. P. M., Ewals, J. A. P. M., Han, K. H., Hazes, J. M. W., Kerstens, P. J. S. M., Peeters, A. J., van Zeben, D., Breedveld, F. C., Huizinga, T. W. J., Dijkmans, B. A. C. and Allaart, C. F. (2009), Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis. Arthritis & Rheumatism, 61: 4–12. doi: 10.1002/art.24367

Author Information

  1. 1

    Leiden University Medical Center, Leiden, The Netherlands

  2. 2

    VU University Medical Center, Amsterdam, The Netherlands

  3. 3

    Haga Hospital, The Hague, The Netherlands

  4. 4

    Rijnmond-Zuid Medical Center, Rotterdam, The Netherlands

  5. 5

    Erasmus University Medical Center, Rotterdam, The Netherlands

  6. 6

    Jan van Breemen Institute, Amsterdam, The Netherlands

  7. 7

    Reinier de Graaf Gasthuis, Delft, The Netherlands

  8. 8

    Sint Franciscus Gasthuis, Rotterdam, The Netherlands

  1. ‡

    Dr. van der Kooij has received consultant fees, speaking fees, and/or honoraria (less than $10,000) from Schering-Plough.

  2. §

    Dr. de Vries-Bouwstra has received consultant fees, speaking fees, and/or honoraria (less than $10,000) from Schering-Plough.

  3. Dr. Hazes has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from UCB, Roche, Schering-Plough, and Wyeth.

  4. ‖

    Dr. Breedveld has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Wyeth, Schering-Plough, and Roche.

  5. ††

    Dr. Dijkmans has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Schering-Plough, Abbott, and Wyeth.

  6. ‡‡

    Dr. Allaart has received speaking fees (less than $10,000) from Schering-Plough.

*Department of Rheumatology C-01-R, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands

  1. †

    ISRCTN: 32675862.

Publication History

  1. Issue published online: 30 DEC 2008
  2. Article first published online: 30 DEC 2008
  3. Manuscript Accepted: 12 SEP 2008
  4. Manuscript Received: 28 MAR 2008

Funded by

  • Dutch College of Health Insurances
  • Centocor, Inc.
  • Schering-Plough BV

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (204K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M. P. Staples, L. March, M. Lassere, C. Reid, R. Buchbinder, Health-related quality of life and continuation rate on first-line anti-tumour necrosis factor therapy among rheumatoid arthritis patients from the Australian Rheumatology Association Database, Rheumatology, 2010, 50, 1, 166

    CrossRef

  2. 2
    C. M. Simonaro, Y. Ge, E. Eliyahu, X. He, K. J. Jepsen, E. H. Schuchman, Involvement of the Toll-like receptor 4 pathway and use of TNF-  antagonists for treatment of the mucopolysaccharidoses, Proceedings of the National Academy of Sciences, 2009, 107, 1, 222

    CrossRef

  3. 3
    Tessa Sanderson, John Kirwan, Patient-reported outcomes for arthritis: Time to focus on personal life impact measures?, Arthritis Care & Research, 2009, 61, 1
    Direct Link:
  4. 4
    Naomi B Klarenbeek, Cornelia F Allaart, Pit JSM Kerstens, Tom WJ Huizinga, Ben AC Dijkmans, The BeSt story: on strategy trials in rheumatoid arthritis, Current Opinion in Rheumatology, 2009, 21, 3, 291

    CrossRef

View Full Article (HTML) Get PDF (204K)